c*d
2 楼
DNDN has a shitty prostate cancerdrug. Nobody uses it.
New better oral drugs coming out fast.
Provenge is a joke.
I do not think anybody in the right mind will buy it.
New better oral drugs coming out fast.
Provenge is a joke.
I do not think anybody in the right mind will buy it.
s*1
3 楼
关注很久了，等机会上车
n*e
4 楼
the biggest drawback is the cost to make this drug. if bigger company
acquire them, the cost could drop a lot. win-win for both sides.
【在 c*****d 的大作中提到】
: DNDN has a shitty prostate cancerdrug. Nobody uses it.
: New better oral drugs coming out fast.
: Provenge is a joke.
: I do not think anybody in the right mind will buy it.
acquire them, the cost could drop a lot. win-win for both sides.
【在 c*****d 的大作中提到】
: DNDN has a shitty prostate cancerdrug. Nobody uses it.
: New better oral drugs coming out fast.
: Provenge is a joke.
: I do not think anybody in the right mind will buy it.
c*d
5 楼
no, even it is free, few will use it.
The benefit is so elusive: does not drop PSA or disease burden, only very
modest survival data (hard to convince patients or MD to use it)l
There are much better drugs now.
Stay away if not short it to zero.
The benefit is so elusive: does not drop PSA or disease burden, only very
modest survival data (hard to convince patients or MD to use it)l
There are much better drugs now.
Stay away if not short it to zero.
相关阅读
差了1.2，博彩输了20块今天如果暴跌200+，盘末无回抽，那下一站就是12000了我要封一个人，你们不要阻止我。擦，这周intel惨了被发了4刀dividendFacebook iOS新版开发手记：两倍速度的背后日本绝世武功高手被人打得落花流水同学们，要想射的远，得要先拉弓买了5股IVV，$141.06质问美国发言人钓鱼岛的中国记者英语真好，气场也足！ (转载)1400点聊Zijing, please say say market..今年还亏损6%什么时候补仓比较好？路专利公司加油Re: 转载：美国物价涨幅惊人：这四年特别恐怖 (转载)全仓无脑爆乳APA？外企在中国裁员手段太落后了，得向民企取经！ (转载)不可思议